NO20011402D0 - Tricykliske <delta>3-piperidiner som farmasøytiske midler - Google Patents
Tricykliske <delta>3-piperidiner som farmasøytiske midlerInfo
- Publication number
- NO20011402D0 NO20011402D0 NO20011402A NO20011402A NO20011402D0 NO 20011402 D0 NO20011402 D0 NO 20011402D0 NO 20011402 A NO20011402 A NO 20011402A NO 20011402 A NO20011402 A NO 20011402A NO 20011402 D0 NO20011402 D0 NO 20011402D0
- Authority
- NO
- Norway
- Prior art keywords
- parta
- piperidines
- tricyclic
- pharmaceutical agents
- pharmaceutical
- Prior art date
Links
- 239000008177 pharmaceutical agent Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Reproductive Health (AREA)
- Ophthalmology & Optometry (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Gynecology & Obstetrics (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98203371 | 1998-10-06 | ||
| PCT/EP1999/007420 WO2000020423A1 (en) | 1998-10-06 | 1999-10-01 | Tricyclic δ3-piperidines as pharmaceuticals |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20011402L NO20011402L (no) | 2001-03-20 |
| NO20011402D0 true NO20011402D0 (no) | 2001-03-20 |
Family
ID=8234192
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20011402A NO20011402D0 (no) | 1998-10-06 | 2001-03-20 | Tricykliske <delta>3-piperidiner som farmasøytiske midler |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US6352999B1 (et) |
| EP (1) | EP1119570B1 (et) |
| JP (1) | JP4590102B2 (et) |
| KR (1) | KR20010071844A (et) |
| CN (1) | CN1131868C (et) |
| AR (1) | AR023679A1 (et) |
| AT (1) | ATE269337T1 (et) |
| AU (1) | AU759199B2 (et) |
| BG (1) | BG64871B1 (et) |
| BR (1) | BR9913108A (et) |
| CA (1) | CA2346082C (et) |
| CZ (1) | CZ20011105A3 (et) |
| DE (1) | DE69918148T2 (et) |
| EE (1) | EE04680B1 (et) |
| ES (1) | ES2222735T3 (et) |
| HU (1) | HUP0103749A3 (et) |
| ID (1) | ID28451A (et) |
| IL (2) | IL142444A0 (et) |
| NO (1) | NO20011402D0 (et) |
| NZ (1) | NZ510116A (et) |
| PL (1) | PL347179A1 (et) |
| RU (1) | RU2226194C2 (et) |
| SK (1) | SK285386B6 (et) |
| TR (1) | TR200100953T2 (et) |
| TW (1) | TWI244485B (et) |
| UA (1) | UA70961C2 (et) |
| WO (1) | WO2000020423A1 (et) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA69420C2 (uk) * | 1998-10-06 | 2004-09-15 | Янссен Фармацевтика Н.В. | ТРИЦИКЛІЧНІ <font face="Symbol">D3</font>-ПІПЕРИДИНИ ЯК <font face="Symbol">a<sub></font>2</sub>-АНТАГОНІСТИ |
| MXPA04000036A (es) * | 2001-07-05 | 2004-05-21 | Upjohn Co | Benzofuranos sustituidos con (hetero) arilo como ligandos 5-ht. |
| AU2003219199A1 (en) * | 2002-04-03 | 2003-10-13 | Orion Corporation | Use of an alfa2-adrenoreceptor antagonist for cns-related diseases |
| AU2005233456A1 (en) | 2004-04-12 | 2005-10-27 | Taisho Pharmaceutical Co., Ltd. | Cyclic amine compound |
| EP1856126A2 (en) | 2005-02-17 | 2007-11-21 | Wyeth a Corporation of the State of Delaware | Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives |
| DE102005038947A1 (de) * | 2005-05-18 | 2006-11-30 | Grünenthal GmbH | Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln |
| US9771348B2 (en) | 2013-07-25 | 2017-09-26 | Dong-A St Co., Ltd | Method for preparing benzamide derivative, novel intermediate used in preparation of benzamide, and method for preparing novel intermediate |
| CN103755715B (zh) * | 2013-12-26 | 2015-12-09 | 武汉理工大学 | 苯并呋喃并[2,3-c]吡啶化合物及其合成方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU926914A1 (ru) * | 1980-05-26 | 1992-04-23 | Научно-исследовательский институт фармакологии АМН СССР | Производные 1,2,3,4-тетрагидробензофуро[3,2-с]-пиридина или хлоргидрат, обладающие р дом свойств анальгетиков и антагонистов морфина |
| DE3522959A1 (de) | 1985-06-27 | 1987-01-08 | Merck Patent Gmbh | Indolderivate |
| US4673680A (en) * | 1985-09-18 | 1987-06-16 | Pendleton Robert G | α2 -adrenergic receptor antagonists as modifiers of gastrointestinal motility |
| JPH0256485A (ja) * | 1988-04-27 | 1990-02-26 | Glaxo Group Ltd | ラクタム誘導体 |
| US4971974A (en) * | 1988-06-16 | 1990-11-20 | Neurex Corporation | Benzothiophenes as appetite suppressants |
| US5100891A (en) * | 1991-01-18 | 1992-03-31 | Hoechst-Roussel Pharmaceuticals Inc. | Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[B]indoles and related compounds |
| DK0942911T3 (da) * | 1996-12-06 | 2002-12-02 | Abbott Lab | Benzopyranopyrroler og benzopyranopyridiner med alfa-1-adrenerg virkning |
| UA52681C2 (uk) * | 1997-04-08 | 2003-01-15 | Янссен Фармацевтика Н.В. | Похідні 1,2,3,4-тетрагідро-бензофуро[3,2,-c]піридину, спосіб їх одержання та фармацевтична композиція на їх основі |
| UA69420C2 (uk) * | 1998-10-06 | 2004-09-15 | Янссен Фармацевтика Н.В. | ТРИЦИКЛІЧНІ <font face="Symbol">D3</font>-ПІПЕРИДИНИ ЯК <font face="Symbol">a<sub></font>2</sub>-АНТАГОНІСТИ |
-
1999
- 1999-10-01 AU AU63342/99A patent/AU759199B2/en not_active Ceased
- 1999-10-01 IL IL14244499A patent/IL142444A0/xx active IP Right Grant
- 1999-10-01 RU RU2001111811/04A patent/RU2226194C2/ru not_active IP Right Cessation
- 1999-10-01 KR KR1020017000443A patent/KR20010071844A/ko not_active Ceased
- 1999-10-01 EE EEP200100210A patent/EE04680B1/et not_active IP Right Cessation
- 1999-10-01 NZ NZ510116A patent/NZ510116A/xx unknown
- 1999-10-01 HU HU0103749A patent/HUP0103749A3/hu unknown
- 1999-10-01 BR BR9913108-0A patent/BR9913108A/pt not_active Application Discontinuation
- 1999-10-01 TW TW088116897A patent/TWI244485B/zh not_active IP Right Cessation
- 1999-10-01 PL PL99347179A patent/PL347179A1/xx not_active Application Discontinuation
- 1999-10-01 CN CN998116688A patent/CN1131868C/zh not_active Expired - Fee Related
- 1999-10-01 ES ES99950628T patent/ES2222735T3/es not_active Expired - Lifetime
- 1999-10-01 EP EP99950628A patent/EP1119570B1/en not_active Expired - Lifetime
- 1999-10-01 TR TR2001/00953T patent/TR200100953T2/xx unknown
- 1999-10-01 CZ CZ20011105A patent/CZ20011105A3/cs unknown
- 1999-10-01 SK SK433-2001A patent/SK285386B6/sk unknown
- 1999-10-01 DE DE69918148T patent/DE69918148T2/de not_active Expired - Lifetime
- 1999-10-01 ID IDW20010779A patent/ID28451A/id unknown
- 1999-10-01 US US09/806,587 patent/US6352999B1/en not_active Expired - Lifetime
- 1999-10-01 CA CA2346082A patent/CA2346082C/en not_active Expired - Fee Related
- 1999-10-01 AT AT99950628T patent/ATE269337T1/de not_active IP Right Cessation
- 1999-10-01 WO PCT/EP1999/007420 patent/WO2000020423A1/en not_active Ceased
- 1999-10-01 UA UA2001032000A patent/UA70961C2/uk unknown
- 1999-10-01 JP JP2000574535A patent/JP4590102B2/ja not_active Expired - Fee Related
- 1999-10-05 AR ARP990105041A patent/AR023679A1/es active IP Right Grant
-
2001
- 2001-03-12 BG BG105334A patent/BG64871B1/bg unknown
- 2001-03-20 NO NO20011402A patent/NO20011402D0/no not_active Application Discontinuation
- 2001-04-04 IL IL142444A patent/IL142444A/en not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20014412D0 (no) | Forbindelser nyttige som anti-inflammatoriske midler | |
| NO20013671L (no) | Substituerte bisycliske derivater nyttige som anticancer midler | |
| DE60013221D1 (de) | Fotopolymerisierbare Zusammensetzung | |
| DK1212327T3 (da) | Pyrazolopyrimidiner som terapeutiske midler | |
| DE50007817D1 (de) | Mikrospiegel | |
| EE200100525A (et) | Adamantaani derivaadid | |
| NO20015477L (no) | 4,5,6,7-tetrahydroindazolderivater som antitumormidler | |
| IS2246B (is) | Adamantanafleiður | |
| IS6405A (is) | Adamantanafleiður | |
| NO20002217D0 (no) | Cyclopentan-heptansyre, 2-heteroarylalkenylderivater som terapeutiske midler | |
| ATE293104T1 (de) | Thiazolylamid-derivate | |
| DK0975623T3 (da) | Indazolamidforbindelser som sertoninerge midler | |
| PT1237857E (pt) | Novos derivados fenalquiloxi-fenilo | |
| DK1086097T3 (da) | Sulfonylbenzenforbindelser som anti-inflammatoriske/analgetiske midler | |
| NO991560D0 (no) | PDE IV som inhiberer 2-cyanoiminoimidazol-derivater | |
| DE50015811D1 (de) | Retardersystem | |
| DE60016836D1 (de) | Resistzusammensetzung | |
| ATE273272T1 (de) | Mevinolinderivate | |
| NO20014926L (no) | Farmasöytiske forbindelser | |
| ATE374747T1 (de) | Monofluoralkylderivate | |
| ATE293592T1 (de) | Resorcinderivate | |
| ATE254598T1 (de) | 4-hydroxybiphenylhydrazid-derivate | |
| DE50015381D1 (de) | Retardersystem | |
| NO20011402L (no) | Tricykliske <delta>3-piperidiner som farmasöytiske midler | |
| NO20011270L (no) | Tricykliske <delta>3-piperidiner som <alfa>2-antagonister |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |